{"Symbol": "DGX", "AssetType": "Common Stock", "Name": "Quest Diagnostics Incorporated", "Description": "Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.", "CIK": "1022079", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DIAGNOSTICS & RESEARCH", "Address": "500 PLAZA DRIVE, SECAUCUS, NJ, UNITED STATES, 07094", "OfficialSite": "https://www.questdiagnostics.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "23012706000", "EBITDA": "2231000000", "PERatio": "23.64", "PEGRatio": "1.667", "BookValue": "65.18", "DividendPerShare": "3.2", "DividendYield": "0.0155", "EPS": "8.75", "RevenuePerShareTTM": "99.41", "ProfitMargin": "0.0899", "OperatingMarginTTM": "0.137", "ReturnOnAssetsTTM": "0.0641", "ReturnOnEquityTTM": "0.147", "RevenueTTM": "11035000000", "GrossProfitTTM": "3677000000", "DilutedEPSTTM": "8.75", "QuarterlyEarningsGrowthYOY": "0.1", "QuarterlyRevenueGrowthYOY": "0.071", "AnalystTargetPrice": "216.44", "AnalystRatingStrongBuy": "2", "AnalystRatingBuy": "7", "AnalystRatingHold": "8", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "1", "TrailingPE": "23.64", "ForwardPE": "19.65", "PriceToSalesRatioTTM": "2.085", "PriceToBookRatio": "3.181", "EVToRevenue": "2.607", "EVToEBITDA": "13.37", "Beta": "0.675", "52WeekHigh": "213.2", "52WeekLow": "155.09", "50DayMovingAverage": "183.49", "200DayMovingAverage": "180.07", "SharesOutstanding": "110242000", "SharesFloat": "109424000", "PercentInsiders": "0.395", "PercentInstitutions": "99.915", "DividendDate": "2026-01-28", "ExDividendDate": "2026-04-06"}